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During cortical development, proliferating neural progenitors exhibit polarized apical and basolateral membranes that are
maintained by tightly controlled and membrane-speci�c vesicular traﬃcking pathways. Disruption of polarity through impaired
delivery of proteins can alter cell fate decisions and consequent expansion of the progenitor pool, as well as impact the integrity of
theneuroependymal lining. Lossofneuroependymal integrity disruptsradial glial scaﬀoldingandaltersinitial neuronal migration
from the ventricular zone. Vesicle traﬃcking is also required for maintenance of lipid and protein cycling within the leading and
trailingedgeofmigratoryneurons,aswellasdendritesandsynapsesofmatureneurons.Defectsinthistransportmachinerydisrupt
neuronal identity, migration, and connectivity and give rise to a malformation of cortical development termed as periventricular
heterotopia (PH). PH is characterized by a reduction in brain size, ectopic clusters of neurons localized along the lateral ventricle,
andepilepsyanddyslexia.eseanatomicalanomaliescorrelatewithdevelopmentalimpairmentsinneuralprogenitorproliferation
andspeci�cation,migrationfromlossofneuroependymalintegrityandneuronalmotility,andaberrantneuronalprocessextension.
GenescausalforPHregulatevesicle-mediatedendocytosisalonganactincytoskeletalnetwork.ispaperexplorestheroleofthese
dynamic processes in cortical development and disease.
1. Cortical Development
e development of the mature six-layered cerebral cortex
involves a highly ordered and complex sequence of events
that requires tight control of neural progenitor cell prolif-
eration, cell fate speci�cation, and initial migration from
their site of origin. Neuroblasts must then migrate to their
�nal destination and undergo region-speci�c diﬀerentiation.
Many excitatory neurons within the cerebral cortex originate
from the pseudostrati�ed ventricular epithelium that lines
the embryonic cerebral ventricle wall [1]. e ventricular
epithelium is composed of bipolar neural progenitor cells
that span the ventricular to pial surface, so-termed neu-
roepithelial cells. Neuroepithelial cells exhibit characteristic
epithelial features including the polarized localization of
transmembrane proteins along their apical plasma mem-
brane (prominin-1) and the localization of adherens junc-
tions along their basolateral plasma membrane [2]. At �rst,
these cells undergo several rounds of symmetric cell division
to produce two identical daughter cells that continue to
proliferate [1]. e consecutive rounds of symmetric cell
division result in the generation of increasing numbers of
neural progenitors and rapid expansion of the ventricular
zone thereby enlarging the surface area of the cortex [3].
At the onset of neurogenesis, which occurs approximately
during the �h week of gestation in humans (or embry-
onic day 11 in mice) some neuroepithelial cells adopt an
asymmetric mode of cell division [4, 5]. In this asymmetric
modeofcelldivision,onedaughtercellretainscharacteristics
of the parent cell and continues to proliferate while the
other daughter cell does not undergo mitosis but rather
migrates towards the pial surface of the cortex [1]. e
transition from symmetric to asymmetric cell division (shi
in cell fate and decision to initiate migration) coincides
with an increase in cortical thickness [3]. Neural progenitors
which initially migrate from the VZ and adopt positions
in the subventricular or intermediate zones may undergo
several additional cycles of ampli�cation, generating either
pairs of new neurons or pairs of intermediate progeni-
tors [6–8]. As neurogenesis continues, neuroepithelial cells2 Scienti�ca
downregulate their epithelial characteristics to form a new
type of progenitor cell called radial glial cells. Radial glial
cells display residual neuroepithelial as well as astroglial
properties. Similar to neuroepithelial cells, radial glial cells
extend long bipolar processes from the ventricle to the pial
surface. In contrast to neuroepithelial cells, radial glial cells
express several molecules commonly expressed by astrocytes
including astrocyte-speci�c glutamate transporter (�LAST)
andglial�brillaryacidicprotein(�FA�)[2,9].Mostneurons
within the brain are generated either directly or indirectly
fromradialglialcells,althoughasubpopulationderivesfrom
intermediate progenitors during the middle and later stages
of cortical development [10].
Neuronal migration in humans occurs between gesta-
tional age of 10–20 weeks and immediately follows neuro-
genesis [4]. During this process, neurons born within the
germinal zones (ventricular zone and ganglionic eminences)
migrate radially towards the pial surface resulting in the
formation of six layers of neurons within the cortical plate
[1]. Early birth-dating studies using tritiated thymidine have
shownthatneuronsaccumulatewithintheirrespectivelayers
in an “inside-out” sequence according to their relative birth-
date [11, 12]. ese studies revealed that cells born at
subsequent later stages of cortical development migrate past
earlierborncellsratherthanmerelydisplacingthemoutward
towards the pial surface. As a result of this “inside-out”
pattern of neuronal migration, the earliest-born neurons are
locatedwithinthedeepestcorticallayerswhilethelatestborn
neurons are found super�cially. e formation of cortical
layers begins a�er the �rst neurons generated within the
ventricular zone migrate towards the pial surface. Neurons
born from the earliest rounds of neurogenesis will migrate
outoftheventricularzonetoformalayerofcellsbeneaththe
pial surface called the preplate. Neurons born from the next
round of neurogenesis will then enter the preplate splitting
this layer into a super�cial marginal zone and an underlying
subplate. Finally, neurons born from subsequent rounds of
neurogenesis will migrate past the subplate to stop just below
the marginal zone which will form layer I of the cortical
plate [13]. e various neocortical laminae (layers II–VI) are
formed as successive waves of migrating neurons reach the
cortex. A series of electron microscopic and tracing studies
have revealed that cells may employ radial or tangential
migratory trajectories in route to the cortical plate. Initial
serial section electron microscopic studies showed that the
entire length of migrating neurons remains closely juxta-
posed to radial glial �bers that span the width of the cortex.
�ased on this �nding, early born neurons were thought to
migrate radially along radial glial scaﬀolding before reaching
their designated positions within the developing cortical
plate [14]. is radial mode of neuronal migration was
subsequently veri�ed in real-time-imaging studies of dye-
labelled migrating cells within the cortex [15]. Subsequent
studies indicate that neurons also migrate tangentially to
the cortex. Retroviral tracing studies suggested that clonally
relatedcellsdispersewidelyratherthanremainalongasingle
radial glial scaﬀold [16]. Imaging studies of dye-labelled
cells within the cortex revealed that both postmitotic and
precursor cells disperse tangentially across radial glial �bers
during neuronal migration [15, 17, 18]. More recent studies
have shown that virtually all interneurons of the cerebral
cortex are produced in the ganglionic eminence of the basal
forebrain and arrive in the cortex in a ventral-to-dorsal
tangential migratory pathway [19, 20]. Once interneurons
reach the cortex, they adopt both radial and oblique routes
towards their �nal destination within the cortical plate [21].
Ultimately, this wave of migratory neurons forms the various
cortical layers: (II) the external granular layer with small
pyramidal neurons and numerous stellate neurons, (III) the
external pyramidal layer, containing small- and medium-
size pyramidal neurons, as well as nonpyramidal neurons,
(IV) the internal granular layer with stellate and pyramidal
neurons that receive thalamocortical aﬀerents, (V) the inter-
nal pyramidal layer comprised of large projection pyramidal
neurons that send signals to the basal ganglia and spinal
cord, and (VI) the multiform layer consisting of pyramidal,
spindle-like, and multiform neurons which send eﬀerents to
the thalamus.
2. Malformations of Cortical Development
Disruptions in one or more aspects of corticogenesis (pro-
liferation, migration, and diﬀerentiation) can give rise
to a group of abnormal brain developmental syndromes
called cortical malformation disorders. ese disorders have
recently been reclassi�ed into subgroups based upon their
anatomical abnormalities and the shared pathways and
mechanisms of action for the speci�c classi�cations: malfor-
mations secondary to abnormal neuronal and glial prolifera-
tion or apoptosis, malformations due to abnormal neuronal
migration, and malformations secondary to abnormal post-
migrational development [22].
In a simplistic view, initial cortical development requires
expansion and generation of suﬃcient neural progenitors.
Many genes causal for proliferative disorders such as the
primarymicrocephalies(smallbrain)areexpectedlyinvolved
in various pathways implicated in cell cycle and cell division
including transcriptional regulation, cell cycle progression
andcheckpointregulation,centrosomeduplicationandrepli-
cation,mitoticspindleformation,andDNArepair[23].More
focal dysplasias (abnormal focal growth of cells) appear to
involve genes that regulate the integration of various cues
such as growth factors, cell cycle signals, and nutrients that
can direct proliferation of smaller cell populations [24].
Following expansion of the progenitor pool, cells must
migrate into the cortical plate. Abnormalities in neuronal
migration have been thought to give rise to periventricular
heterotopia(nodulesofneuronsalignedalongthelateralven-
tricles), subcortical heterotopias (ectopic clusters of neurons
typically localized between the ependyma and the cortex),
and lissencephalies (disruption in migration along the entire
extent of the cortical width). Taken in the context of the
anatomicalabnormality,periventricularheterotopiahasbeen
viewed as a disruption in initial neuronal migration due to
disruption of the ventricular neuroepithelium [25]. Loss of
ependymal integrity may cause disengagement of radial glial
end feet along the denuded epithelium, thereby preventingScienti�ca 3
early postmitotic neurons from migrating into the cortical
plate. Genes causal for this disorder play some role in actin
regulation and vesicle traﬃcking [26–29]. Widespread dis-
ruptionoftransmantlemigrationcanleadtogrossdisruption
of lamination and cortical folding with agyria, widened
sulci, and gyri formation as in pachygyria and subcortical
band heterotopia. Not surprisingly, many genes that lead to
disruption of neuronal migration and motility appear to play
some role in microtubule function [30–32].
Following migration, neurons which reach the cortical
p l a t eb u td e v e l o pa b n o r m a l l yc a ng i v er i s et os o m ep o o r l y
understood cortical malformations. Polymicrogyria (refer-
ring to multiple small gyri along the cortical surface) and
schizencephaly (characterized by grey matter tissue extend-
ing from the ependymal lining of the cerebral ventricles
to the pial surface of the cerebral hemisphere surface) are
heterogeneous disorders. e underlying pathophysiology is
poorly understood.
3. Periventricular Heterotopia
Periventricular heterotopia (PH) refers to a malformation
of cortical development characterized by bilateral near-
contiguous ectopic neuronal nodules found along the lateral
ventricles (so-termed periventricular heterotopia) [33]. e
nodules are thought to re�ect impaired migration from the
VZ. Some individuals harboring mutations in the causative
genes also have microcephaly (meaning small brain), sug-
gestive of impaired neuronal generation or increased cell
death [26, 34]. Overall, these observations suggest that genes
involved in PH formation play some role in migration
(heterotopia formation) and proliferation (microcephaly).
e anatomical localization of this disorder raises inter-
esting implications for genes that are causal for this disorder.
During normal cortical development, neural progenitors
reside along the VZ, undergo progressive expansion through
proliferation, and then undergo cell fate speci�cation either
to remain as a progenitor, transform into an intermediate
progenitor or assume a postmitotic neuronal fate. Intermedi-
ateprogenitorsandpostmitoticneuronsmustundergoinitial
migration from the VZ toward the cortical plate, whereas
progenitors reenter the cell cycle. Interactions between pro-
genitors and the extracellular environment and regulation of
cell cycle proteins are going to in�uence the developmental
fate of neural progenitors. Given that PH re�ects a devel-
opmental defect speci�cally within this population of cells
during a fairly con�ned temporal framework, genes involved
in this disorder will in all likelihood play a signi�cant role in
regulating neural progenitor proliferation and migration.
4. Genetics Underlying PH Formation
Neurogenetic analyses have identi�ed two human genes are
knowntocausePHformation.emostcommonformofPH
is inherited in an X-linked dominant fashion from mutations
in the FLNA gene [28]. Filamin A encodes the cytoplasmic
actin-binding protein FLNA, which serves as a scaﬀold to
over thirty proteins [35]. Given FLNA interactions with the
actin cytoskeleton, PH has been thought to arise from a
disorder in neuronal motility. rough X-inactivation, cells
harboring the mutant FLNA protein would fail to migrate
from the ventricular zone, whereas cells expressing the nor-
malFLNAproteinundergonormalmigrationintothecortex
[28]. A rare form of autosomal recessive PH with micro-
cephaly (ARPHM) has been associated with mutations in
theARFGEF2gene.ARFGEF2encodesBrefeldin-Ainhibited
Guanine Exchange Factor-2 (BIG2) [26]. BIG2 is a protein
kinase A anchoring protein (AKAP) which regulates Golgi-
vesicle traﬃcking through its Sec7 domain. Although FLNA
and BIG2 proteins appear to carry out diﬀerent functions,
similar radiographic �ndings of PH suggest that they might
be involved in the same molecular pathway important in
neural progenitor development. Moreover, since PH due
to ARFGEF2 mutations is an autosomal recessive disorder,
all migratory neurons harbor the gene mutation. us, it
is unlikely that a cell motility problem alone causes this
m a l f o r m a t i o nb e c a u s eo n l ys o m ea n dn o ta l lt h en e u r o n sf a i l
to migrate from the VZ into the cortical plate.
Other genetic abnormalities have been associated with
this disorder. Anterior PH has been reported with duplica-
tion of human chromosome 5p15 [36]. Diﬀuse but variable
PH is caused by a deletion on 6q27 [37], whereas PH with
diﬀuse white matter changes is associated with 6p25 deletion
[38]. PH and William�s syndrome have been identi�ed and
involved a deletion on 7q11.23 and include the region
spanning the HIP1 and YWHAG genes [37, 39]. Deletion
of chromosome 1p36 gives rise to PH and agenesis of the
corpus callosum [40]. Genomic deletions leading to PH have
also been reported to localize to 4p15, 5q14 [41, 42]. Finally,
triplet CGG nucleotide repeat expansion of the FMR1 gene
can lead to PH in Fragile X [43] ,a sc a nm u t a t i o n si nt h e
polyglutamine repeat binding protein PQBP1[ 44]. Triplet
repeat disorders have similarly been implicated in vesicle
traﬃcking, suggesting a shared common pathway in the
human PH phenotype [45].
Several mouse genes have been associated with PH for-
mation. Stem-cell-factor- (SCF-) c-kit regulates proliferation
and migration of neural progenitor cells. Direct administra-
tion into the ventricles during cortical development led to
neuronal and glial heterotopia as well as disruption of the
neighboring cytoarchitecture [46].
Deletion of the rho GTPases Cdc42 also disrupts local
adherens junctions and proliferation of basal progenitors
leading to heterotopia formation through both impaired
intranuclear migration and disruption of the neuroependy-
mal lining [47]. Spred1, a negative regulator of Ras-MAPK-
ERK, similarly leads to PH formation. In cortical progenitor
cells, Spred1 localizes within distinct vesicles, indicating a
potential role in transport [48]. Mekk4 binds FlnA and
regulates the CSBP2 and JNK MAPK (but not the mitogen-
activatedERKMAPK)pathwayswhichareactivatedbyenvi-
ronmental stresses such as osmotic shock, UV irradiation,
wound stress, and in�ammatory factors [49]. PH is also
seen in mutations in the Napa gene, which encodes for
soluble N-ethylmaleimide-sensitive factor (NSF) attachment
proteinalpha(alphaSnap)andisinvolvedinSNAPreceptor-
(SNARE-) mediated vesicle fusion [25, 50].4 Scienti�ca
5. Filamin A and PH
5.1. Genetic Phenotype. While mutations in FLNA are the
most common cause of inherited PH in the central nervous
system (CNS) [51], it has become increasingly clear that
disruptions in the function of this actin-binding protein
are not limited to the brain. Understanding its function
both inside and outside the CNS will provide insight into
fundamentalrolethatthisandassociatedinteractingproteins
play in PH, its related phenotypes, and ultimately neural
progenitor development.
In the CNS, familial PH is associated with an X-linked
dominant inheritance pattern such that males are hem-
izygous lethal and females present with the classical PH
phenotype. In females, X-inactivation leads to a proportion
of cells which normally expresses FLNA whereas others have
noproteinexpression.Inadditiontothebilateralheterotopic
nodules, the disorder is associated with thinning of the
corpuscallosumandanenlargedcisternmagna.Femalescan
develop varying degrees of epilepsy and dyslexia, as well as
worse adaptive skills and conduct problems [52, 53]. e
complete loss of FLNA phenotype in males is more severe
withathinnedbutnormalsixlayeredcortex.Polymicrogyria,
thinning of the corpus callosum, enlarged ventricles, and
reduced white matter are seen in hemizygous males. e
brainstem and cerebellum are unaﬀected [54, 55].
Mutations in FLNA have been increasingly recognized to
aﬀect extra-CNS organ systems in giving rise to phenotypic
heterogeneity [56, 57]. �obertson identi�ed mutations in
the actin-binding gene as causal for four skeletal dysplasias
(otopalatodigital syndrome OPD types 1 and 2, frontometa-
physeal dysplasia, and Melnick-Needles syndrome) with
abnormalities in craniofacial structures, skeleton, brain, vis-
cera, and urogenital tract. Mutations in FLNA clustered into
four regions of the gene, the actin-binding domain and rod
domain repeats 3, 10, and 14/15, suggesting some type of
gain of function phenotype [58, 59]. However, an in-frame
deletion on repeat 24 also produces PH with similar skeletal
changes suggestive of OPD associated with �at face and spat-
ulate �nger tips, short broad phalanx and metacarpus, and
bowedradiuswithdislocatedwristjointsinmales,suggesting
that this may not just be a gain of function mechanism [60].
FLNA mutations have also been associated with cutaneous
manifestations such as terminal osseous dysplasia (exon 31)
and the connective tissue disorder, Ehlers-Danlos syndrome
(EDS) [27, 61, 62]. Cardiac valvular disease (repeat 1, 4,
and 5) and vascular abnormalities are commonly seen in
this disorder. FLNA mutations typically give rise to aortic or
mitral regurgitation, coarctation of the aorta, or other le-
sided cardiac malformations [63, 64]. Moreover, the early
embryonic lethality seen in null FLNA mutations in males
likely arises from excessive bleeding due to a vasculopathy.
FLNA plays a role in lung development and loss of func-
tion has been reported to cause lobar emphysema, bilateral
atelectasis, lung cysts, and tracheobronchomalacia, leading
to pulmonary arterial hypertension and long-term oxygen
dependence [65, 66]. e defects appear in-part secondary
to defects in the formation of bronchial cartilage. Finally,
FLNA dysfunction and PH have been linked to intestinal
pseudoobstruction. Pathology showed abnormal lamination
ofthesmallintestinalmuscularispropriaandmultinucleated
myocytes [67–69]. Individuals with the pseudoobstruction
also variably presented with patent ductus arteriosus, and
thrombocytopeniawithgiantplatelets,furtherreiteratingthe
broad multiorgan system involvement of FLNA [69].
Several observations can be drawn from the various
phenotypesreportedlyduetoFLNAmutations.First,hetero-
topiae are not the only anatomical malformation seen in the
CNS with this disorder. e reduced cortical layer width and
mentalretardationseeninmaleswiththisdisorderimplicates
FLNA in neural progenitor proliferation. e thinning of
corpus callosum, dyslexia, and epilepsy also argues that
FLNA is likely involved in neuronal process extension and
formation. Second, FLNA is broadly expressed throughout
the body and its phenotypes do not always appear to be
fully penetrant, suggesting that there are extrinsic factors
which modify the clinical presentation. ird, some shared
features are seen in the abnormalities within the diﬀerent
organ systems. As with the brain where there appears to
be disruption of the cell connectivity and adhesion along
the neuroependyma [25], weakening of skin integrity is
seen in EDS, the vasculopathy has been reportedly due to
leakiness in vessels from loss of vascular endothelium, and
the emphysema and cyst formation in the lungs also could
implicate loss of cell adhesion.
5.2. Structure. FLNA represents one of three members
(FLNA, FLN�, FLNC) of the �lamin family of actin-binding
proteins. e �lamin proteins share a high degree of homol-
ogy between the conserved exon/intron structure with sig-
ni�cant diﬀerences in exon 32 of all paralogs encoding the
hinge I region, as well as the insertion of a novel exon 40A
in FLNC only [70]. Moreover, these proteins are shown to
physicallyinteractandheterodimerize,potentiallysuggesting
a mechanism with which to regulate FLNA function [71].
FLNA is a 280kD actin-binding phosphoprotein repre-
sented by an N-terminal actin-binding domain, followed by
Immunoglobulin- (IG-) like repeat domains, that contains
the receptor binding region at the C-terminus. FLNA asso-
ciates with itself to form a homodimer that can regulate
the actin cytoskeleton through interactions derived from
its multiple receptor binding regions, thereby directing cell
stability, protrusion, and motility [72, 73]. Filamin also
promotes actin branching, tethers large actin �laments, and
holds them in a perpendicular arrangement [74, 75]. e
resulting three-dimensional orthogonal network of actin
�laments represents a characteristic cortical actin structure
at the leading edge of migrating cells. Lastly, FLNA contains
a PKA-dependent phosphorylation site at serine 2152 that
has been shown to regulate its redistribution to the cell
membrane [76].
5.3. Function. FLNAhasbeenshowntointeractwithnumer-
ous other proteins, suggesting many potential mechanistic
roles that could in�uence cortical development. ese inter-
actors demonstrate great diversity but can be clustered into
several general functional groups including (1) interactionsScienti�ca 5
with transmembrane receptors and signaling molecules such
as 𝗽𝗽-integrin, dopamine, and G-protein-coupled calcium
sensing receptors, (2) signaling through diverse intracellular
cell signaling kinases, phosphatases, and adaptor molecules
such as SHIP-2 or SEK1, and (3) regulation of cortical actin
networks through molecules including the Rho family of
small GTPases [35, 77–80].
FLNA has been reported to interact with a vast array of
cell surface receptors. For example, FlnA interactions with
integrins provide a link between the extracellular matrix and
regulation of the actin cytoskeleton [81]. FlnA also binds
dopamine and epidermal growth factor receptors, suggesting
some role in signal transduction of secreted neurotransmit-
ters and growth factors [82, 83]. e androgen receptor also
interacts with the actin-binding protein and the two proteins
colocalizeinthenucleusimplicatingFLNAintranscriptional
regulation[84,85].IntheabsenceofFLNAbinding,thecystic
�brosis transmembrane conductance regulator is rapidly
internalized from the cell surface, where it accumulates
prematurely in lysosomes and is ultimately degraded [86].
Similar FLNA-dependent lysosomal degradation is seen with
the FcgammaRI, a high-aﬃnity IgG, and recycling of cal-
citonin receptors [87, 88]. ese observations indicate that
FLNA not only serves as a means for signal transduction
from receptors onto the actin cytoskeleton and associated
signaling components but also suggests that the protein
actively regulates the turnover and stabilization of receptors.
Following receptor activation, FLNA may alter the cor-
tical actin cytoskeleton. In general, FLNA is thought to
bind and activate RhoGTPases, thereby regulating their
consequenteﬀectorsinvolvedinactindynamics.CD4andits
coreceptors interact with FLNA to direct both the clustering
of these HIV receptors on the cell surface but also mediate
actin assembly and disassembly through a RhoA-ROCK-
dependent mechanism [89]. Filamin A regulates monocyte
migration through Rho small GTPases during osteoclasto-
genesis [90]. FilGAP, a Rho-, and ROCK-regulated GAP for
Racbinds�laminAtocontrolactinremodelling[91].Finally,
endogenous FLNA is phosphorylated by PAK1 (an eﬀector
of Rac1 RhoGTPase) on ser2152 following stimulation with
physiologic signaling molecules [92].
FLNA serves as a scaﬀold in intracellular cell signaling.
For example, the actin-binding protein binds CMIP/TCMIP
which are adaptor proteins involved in the T-cell signaling
pathway [93]. It similarly regulates the activation of Sek-1, a
dual-speci�city protein kinase that is one of the immediate
upstream activators of the stress-activated protein kinases
(SAPKs) [78, 94]. FLNA interacts with Ship-2, a phosphatase
that promotes insulin signaling [77].
Overall, FLNA integrates activation and signaling from
various cell receptors, thereby mediating changes in actin
dynamics through RhoGTPases and directing intracellular
signaling of varied pathways. In this respect, the actin-
binding proteins serve primarily as scaﬀolds that may bring
together certain molecules within a given signaling pathway
through actin assembly and disassembly. Classically, such a
pathway involves extracellular matrix-dependent activation
of integrin receptors, transduction of this signal through
�lamin onto PKC or FILGAP which directly promotes RhoA
and RAC activation and subsequent changes in the actin
cytoskeleton [95, 96].
5.4. Loss of FLNA Function in Mouse Model Studies. Prior
studies have described vascular and skeletal abnormalities in
null FlnA mice and in the Dilp2 mouse [97, 98]. e Dilp2
mouse harborsa T-to-Atransversionthatconverts a tyrosine
codon to a stop codon in the FlnA gene (Y2388X). Loss of
FlnA function in either mice results in embryonic lethality
at E15-16 with severe cardiac structural defects and midline
fusion defects in the skeleton.
FLNA is involved in neural progenitor proliferation. Loss
ofFLNAfunctioninmiceresultsinathinnedcerebralcortex.
Moreover, loss of ventricular surface adherens junction pro-
teins(i.e.,VE-cadherin)alongthebasolateralsurfacesuggests
some disruption in neuroepithelial cell polarity and poten-
tially, cytokinesis [98]. More recent �ndings demonstrate
that the defect in proliferation is secondary to prolongation
in the cell cycle, principally during M phase. FlnA loss
impaired degradation of multiple cyclin-B1-related proteins,
in part, through increased Cdk1 phosphorylation, thereby
delaying the onset and progression through mitosis [99].
e delayed degradation in various cyclin-B-related proteins
raises the possibility that FlnA might play a more prominent
role in regulation of traﬃcking and stabilization of various
molecules. Other studies have also shown that FLNA, like
the Rho GTPase RhoA, is localized to the cleavage furrow
[100], and that FLNA interacts with RhoA and both proteins
are involved in regulation of actin. Taken collectively, these
observations suggest that FLNA may play some role in
cortical progenitor proliferation along the neuroependyma
through RhoA- and actin-dependent traﬃcking of cell fate
determining proteins.
FLNA is involved in initial neural progenitor migra-
tion. In early embryonic lethal (E13.5) null FLNA mice,
migration into the cortical plate was ultimately preserved in
neurons that had incorporated BrdU early in development
[97, 98]. Other studies inhibiting FLNA function within
neural progenitors along the ventricular lining by electro-
poration, however, have shown delayed migration into the
cortical plate [101, 102]. Other studies have described the
development of PH in the mitogen activated protein kinase
kinase 4 (Mekk4) loss of function mice [49]. ese mice
also exhibit impairments in the onset of neural progenitor
migration, disruption of the neuroependymal lining, and
PH formation. Interestingly, FlnA levels were elevated in
these mice, and Mekk4 appears to exist in a complex with
Mkk4 and FlnA [78]. Overexpression of FlnA led to impair-
ments in migration. More recent reports similarly suggest
that the ADP-ribosylation factor guanine exchange factor 2
Arfgef2 (encodes for the protein brefeldin inhibited guanine
exchange factor 2, Big2) physically binds and interacts with
FlnA. Loss of Big2 leads to upregulation of both FlnA and
phospho-FlnA. Phosphorylation of FlnA alters FlnA binding
aﬃnity to actin and changes the size and distribution of
paxillin focal adhesions, thereby altering cell autonomous
migration into the cortex [103]. ese �ndings suggest an
interactive role between vesicle traﬃcking-related proteins
and actin-associated proteins such as FlnA.6 Scienti�ca
6. ARFGEF2 and PH
6.1. Genetic Phenotype. Mutations in ARFGEF2 on chro-
mosome 6 cause a rare autosomal recessive form of PH in
humans. Aﬀected individuals uniformly present with bilat-
eral periventricular nodular heterotopia and microcephaly
with generalized atrophy. Imaging studies tend to show
hyperintensities in the basal ganglia. In one limited report,
mutations in this gene are also associated with severe chore-
adystonic movement disorder [26, 29].
e autosomal recessive PH due to mutations in the
ARFGEF2 gene has been previously described in three
pedigrees [26, 29]. e �rst pedigree displayed a missense
mutation within a highly conserved amino acid (E209K).
e second pedigree displayed a complex mutation (two
missense mutations and one single nucleotide deletion)
which predicted the premature termination of translation of
the protein. e third pedigree showed compound heterozy-
gosity for a duplication (base pairs 2031–2038) and deletion
(base pairs 3798–3802) mutation, both of which led to a
frameshi predicting a premature stop codon [29].
6.2. Genetic Structure and Function. Brefeldin A guanine
exchange factor 2 (BIG2) is a 180kDa protein which belongs
to a family of three highly conserved large molecular weight
mammalian Sec7-GEFs (GBF1, BIG1/2) [104]. ey are
distinguished by their sensitivity to the fungal metabolite
Brefeldin-A (BFA) [105, 106]. e Sec7 domain is the most
highly conserved region of the GEF family and is responsible
for the GDP-to-GTP exchange and activation of ARFs [107–
111].BIG2localizesalongtheGolgiandrecyclingendosomes
andisthoughttocarryoutARF-dependentvesicletraﬃcking
along these subcellular compartments [112]. Exo70, a mem-
ber of the exocyst complex involved in vesicle exocytosis,
also binds the N-terminal of BIG2 [37, 43]. Within its
Exo70 binding region, several AKAP (A-kinase anchoring
protein) binding sites are located. BIG2 residues 27–48
interact with PKA (protein kinase A) subunits RIalpha and
RIbeta, residues 284–301 interact with subunits RIIalpha
and RIIbeta, and residues 517–538 interact with subunits
RIalpha, RIIalpha, and RIIbeta [113, 113]. Finally, at its C-
terminal, BIG2 has been shown to bind the beta subunit
of GABA receptors [114]. As a kinase anchoring protein,
BIG2 is implicated in the spatiotemporal activation of cAMP
signaling [115] and PKA-dependent phosphorylation also
appearstoregulateBIG2activationoftheARFs[116].Finally,
as discussed below, Big2 has been shown to bind FlnA.
e ARFs are members of the Ras family GTPases
involved in lipid vesicle budding from the membrane. ey
aregenerallymyristoylatedattheN-terminaldomaintoallow
for membrane association and undergo cycling between the
GTP and GDP-bound states. e active GTP form leads
to a conformational change that exposes the myristate and
hydrophobic N-terminal, thereby allowing for association
with the membrane. e activated ARF binds to vesicle
coat proteins and adaptors, including coat protein I (COPI)
andvariousphospholipids.Guanineexchangefactors(GEFs)
such as BIG2 mediate ARF activation (GDP to GTP),
whereas ARF GTPase activating proteins (GAPs) hydrolyze
ARF-GTP back to ARF-GDP at the membrane. In the GDP-
conformational state, the ARF becomes less hydrophobic
and dissociates from the membrane. ere are in total six
ARF isoforms in mammals, which are grouped into three
classes (Class I ARFs 1–3, Class II ARF4-5, Class III ARF
6) [117]. BIG2 has been shown to activate ARFs 1 and
3 in vivo through GTP activation[112]. ARF1/3 regulates
cholera toxin-mediated endocytosis as well as endosome to
endosome fusion. Moreover, dominantly active ARF1 can
antagonize the inhibiting eﬀects of Brefeldin A (an inhibitor
of BIG2 function) [118, 119].
6.3. Loss of Arfgef2 Function in Mouse Model Studies. e
functional role of Big2 in the CNS is not well understood.
BIG2expressionisdevelopmentallyregulatedduringcortical
development and is most strongly localized to the neural
progenitor cells along the neuroependymal lining of the
ventricular zone during embryonic development. Expression
ofBIG2islaterdownregulatedduringpostnataldevelopment
andadulthood[120].Recentworksuggestedearlyembryonic
lethalityinanArfgef2gene-trapmousemodel,withinsertion
aer exon 7. Fertilized eggs fail to develop aer the four
stage embryo [121]. is model, however, likely re�ects a
gain of Big2 function given that humans a second published
transgenic model which creates a frameshi aer exon 2,
resulting in viable mice [103]. e loss of Big2 function
mice develops heterotopia in the context of an underlying
exencephaly which presumably disrupts the ventricular lin-
ing. ese observations would suggest that PH is largely due
to extrinsic disruption, likely of adhesion between cell-cell
contactsalongtheneuroependyma.emicealsocanexhibit
midline closure defects, as seen with the FlnA mice. Finally,
they do exhibit defects in neuronal migration, indicating
some impairment in cell autonomous processes that regulate
neuronalmotility.However,thisisnotsuﬃcienttocausePH.
7. General Mechanismsof VesicularTraﬃcking
e endoplasmic reticulum (ER) is the primary site of lipid
and protein synthesis in a cell, and vesicle budding from
the ER provides a means with which to distribute proteins
to their designated cellular location. ese transport vesicles
are de�ned by their lipid composition and protein coats,
with coat proteins I/II (COPI/II) mediating protein/lipid
export from the ER and Golgi. Rab GTPases are peripheral
membrane proteins that are anchored into the membrane
and regulate many steps of membrane traﬃc, including
vesicle formation, vesicle movement along actin and tubulin
networks, and membrane fusion. e composition of these
various proteins mediates the transport to other endosome
compartments or the plasma membrane [122, 123].
Endocytosis is a process characterized by four gen-
eral mechanisms: clathrin-mediated endocytosis, caveolae,
macropinocytosis, and phagocytosis [124]. Clathrin proteins
form coated pits that cover the surface of an endosome.
e coated pits concentrate large extracellular molecules
that have diﬀerent receptors responsible for the receptor-
mediated endocytosis of ligands (i.e., transferrin and growthScienti�ca 7
factors). On the other hand, caveolin-mediated endocytosis
involves cholesterol binding caveolin proteins which form
�ask shape pits that resemble caves. Internalization is medi-
ated by receptors within the caveolin laden lipid membranes.
Pinocytosis involves the invagination of cellular membrane
and subsequent uptake of smaller molecules and extracellu-
lar �uid into the endosome. Finally, phagocytosis involves
cellular internalization of larger materials (greater than 0.75
microns including cellular debris, apoptotic cells, etc.) and is
performed by specialized cells such as macrophages.
Proteins synthesized in the ER traﬃc to the Golgi and
thenthroughspeci�cendosomalcompartment.Whenendo-
cytosed, these compartment-speci�c proteins enter early
endosomes and are sorted either to late endosomes, lyso-
somes, or degradation/recycling endosomes prior to return
to the parent membrane. Alternatively, the proteins may
undergo transcytosis; this process refers to the transfer of
endocytosedproteinsresidinginonemembrane(i.e.,basolat-
eral)thataresortedandmodi�edincommonendosomesand
then transported to the opposite membrane (i.e., apical). e
movement of vesicles is facilitated by the actin cytoskeletal
networkandassociatedmotorproteinstomaintaintheapical
and basolateral domains [125]. With delivery of the vesicle
tothetargetlipidcompartment,vesicle—SNARE(solubleN-
ethylmaleimide sensitive factor attachment protein receptor)
and target membrane—SNARE proteins bind to tether and
assist in membrane fusion for cargo delivery. Additionally,
the target lipid compartment (lipid ras) oen are composed
ofspeci�cphospholipidsthatassistinsignaltransductionand
as localized areas for vesicle fusion and delivery of speci�c
protein cargo, such as the cell-cell junctional proteins (E-
cadherin).
8. PH as a Defect in the Vesicle
Traﬃcking Machinery
An overriding defect in the vesicle traﬃcking machinery
contributes to PH formation (Figure 1). e characteristic
heterotopic nodules found along the ventricular lining are
thought to arise from a disruption in cell-cell adhesion along
the neuroependymal lining as well as a defect in initial
neuronal migration [25, 101, 103]. Both FLNA and BIG2
expression are highly regulated along the neuroependymal
surface and within neural progenitor cells during embryonic
development [120], and both proteins are implicated in vesi-
cle traﬃcking. FLNA dynamically associates with Golgi and
vesiclemembranesandregulatesthetraﬃckingofmembrane
proteins(furin,transferrinreceptors)aswellascaveolin[126,
127]. BIG2 regulates ARF-dependent vesicle budding along
the Golgi and endosomal membrane compartments [112].
Recent work suggests that Big2 binds FlnA and regulates its
level of phosphorylation [103]. e inhibition of FLNA or
BIG2functionalsoleadstosimilardefectsinthetraﬃckingof
adherens junction proteins (𝗽𝗽-catenin, E-cadherin). Overex-
pression of dominant negative mutant FLNA (actin-binding
de�cient)withinneuralprogenitorcellsalongtheventricular
surface leads to the mislocalization of 𝗽𝗽-catenin from the
basolateral cell membrane [25]. In addition, mice with null
mutationsinFlnagenedisplaythelossofvascularendothelial
cadherin along the neuroependymal surface [98]. Similarly,
overexpression of dominant negative mutant BIG2 (Sec7-
inactivated) leads to the abnormal membrane localization of
𝗽𝗽-catenin and E-cadherin in polarized Madin Darby Canine
Kidney cells (MDCK) [26]. Intraventricular injection of
brefeldin-A leads to the loss of adherens junction proteins
(𝗽𝗽-catenin, N-cadherin) along the neuroependymal surface
and the denudation of the ventricular surface followed by
P Hf o r m a t i o n[ 25]. Overall, these �ndings suggest that an
interaction between actin (FlnA) and vesicle budding (Big2)
leadtodestabilizationofthelipidmembrane,impairmentsin
cell adhesion molecules, and loss of ependymal integrity.
Mouse genes causal for PH collectively suggest a defect
in vesicle traﬃcking in this disorder and appear to be
involved in �lamin-dependent pathways. Alpha SNAP is
a SNARE-related protein, involved in vesicle fusion. Prior
reports have shown that alpha SNAP mediates VE-cadherin
localization through a b1-integrin-associated process [128].
FlnA binds b1-integrin. Mekk4 is a regulator of FlnA and
therefore indirectly regulates caveolin or clathrin-mediated
endocytosis. e rhoGTPases bind FlnA and direct various
aspectsofintracellularactindynamics,whicharerequiredfor
endosomal vesicle transport. In a similar manner, Spred1 is a
multidomainscaﬀoldingproteinthatcontainsanENA/VASP
domain that can modulate actin stress �ber remodeling, in
a manner similar to the �lamins. Spred1 is also associated
with speci�c endosomal vesicles [48]. Finally, SCF-c-kit
eﬀects several downstream pathways including RAS/ERK
andJAK/STATpathways,bothofwhichhavebeenassociated
w i t hM e k k 4a n dS p r e d 1a c t i v i t y[ 129].
Although disruption in the neuroependymal lining may
betheprimarycauseofheterotopiaformation,alteredvesicle
traﬃcking would be expected to contribute to other CNS
and extra-CNS anatomical defects. Several studies have
demonstrated impaired neuronal migration and motility fol-
lowing inhibition or overexpression of FlnA or Big2 function
[49, 101–103]. For example, loss of Big2 function leads
to upregulation of FlnA phosphorylation and changes in
paxillin cluster size and number in migratory neurons [103].
As vesicle traﬃcking re�ects a homeostatic process, both
increases and decreases in traﬃcking-associated proteins
could lead to changes in the localization and stability of
molecules associated with neuronal migration. Loss of FlnA
function also leads to a reduction in brain size secondary
to prolongation in M to G2 phase progression of neu-
ral progenitors and delayed clearance of various cyclin-B-
associated proteins [99]. e impaired degradation of these
proteinsagainsuggests somedefect in vesicletraﬃcking. Not
unexpectedly, these defects in progenitor proliferation also
appear to aﬀect chondroprogenitors and intestinal stem cells,
as loss of �lamin function leads to skeletal midline closure
defects and a shortened gut. Loss of integrity of the lining
canalsobeappreciatedinbloodvesselswheretheembryonic
lethality of null FlnA mice is due to a vasculopathy and
bleeding from breakdown of the endothelial lining [58, 98].8 �cienti�ca
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and the morphology of migratory neurons. Lastly, the loss of neuroependymal integrity giving rise to heterotopia is due to impairments in
the cell adhesion along the ventricular lining. Genes that disrupt vesicle traﬃcking impair cell-cell adhesion and disrupt the integrity of the
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9. FutureDirections
e ventricular neuroepithelium of the cerebral cortex is
a dynamic structure, whose maintenance depends on the
continuous turnover of polarized vesicle traﬃcking. During
cortical development, neuroepithelial cells (neural progen-
itors) give rise to all the neurons and astrocytes of the
cerebralcortex.ecellfatedecisionofprogenitorsfromself-
renewal to diﬀerentiation is a crucial factor in determining
the morphology and size of the brain. �ell fate speci�cation
is regulated by symmetric and asymmetric divisions, which
are further governed by mitotic spindle orientation. Vesicle
traﬃckingmaintainstheapical-basalpolarityofneuroepithe-
liumthroughdirectionalvesicletransportandvesiclesorting,
thereby dictating cell polarity and symmetric/asymmetric
division. ese mechanisms will also dictate the integrity
of the neuroepithelium, the direction and rate of neuronal
migration, as well as connectivity between neurons. While
FLNA and BIG2, as well as various mouse genes, have been
implicated in endosomal vesicle traﬃcking and defects in
this pathway can give rise to the various neural defects,
the downstream eﬀectors of these processes are not know.
It will be important to determine which actin eﬀectors
(besides the RhoGTPases) are responsible for changes in
actin dynamics through FLNA and which endocytic vesicles
(caveolin, clathrin, etc.) and the stage of endocytosis (early,
late, lysosomal, etc.) through BIG2 are responsible for the
variousphenotypes.Lastly,thedirectinterplaybetweenactin
andvesicletraﬃckingispoorlyunderstoodandstudiesgoing
forward will be aimed at addressing this biological process.
10. Conclusions
Vesicle traﬃcking plays a central role through the various
stages of cortical development, and disruption of theseScienti�ca 9
mechanisms contributes to diﬀerent aspects of cortical mal-
formations. Cyclin-associated proteins regulate the rate of
progression through the cell cycle and thereby dictate neural
progenitor proliferation. e turnover of cyclin-associated
proteins is dependent on vesicles and impaired degradation
leadstoprolongationofthecellcycleandareductioninbrain
size. During neural progenitor expansion cells translocate
from the neuroependymal lining toward the cortical surface
and back again. Neuroependymal integrity is maintained by
cell-cell junctions, which are dependent on vesicle transport.
Disruption of the neuroependymal lining causes displace-
ment of progenitors near the ventricular lining and PH
formation. Next, migrating neurons must travel from the
ventricularzonetothecorticalplate.eleadingandtrailing
processes of migrating neurons require active turnover of
lipid membranes and focal adhesion-associated proteins
for proper motility; disruption of these vesicle-dependent
processes results in impairments in neuronal migration.
Although unproven, it seems likely that the dyslexia and
seizures associated with genes cause for PH will also re�ect
vesicle traﬃcking-related problems in synaptic connectivity.
us, while disorders of vesicle traﬃcking may be linked to
PH formation also, these fundamental processes give rise to
a much broader cortical phenotype than previously realized.
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